Despite its rich natural resources, Myanmar is one of Asia's poorest countries. As such, the country faces serious health challenges. Myanmar is among the top 30 countries for high TB burden, high TB and HIV coinfection and high multidrug-resistant TB. With mass distribution of mosquito nets and artemisinin-based combination therapy, malaria rates have plummeted in recent years. However, Myanmar still accounts for more than half of all malaria deaths in its region. Artemisinin resistance in the Greater Mekong sub-region, including in Myanmar, is a serious global threat, particularly if it crosses to neighboring countries and then onward to Africa. The Global Fund is investing in a regional grant to control the spread of the resistance and push toward malaria elimination.The Global Fund / John Rae
For documents pertaining to a specific grant, please select a grant from the list.